Post-Marketing Surveillance of Gliadel 7.7mg Implant (All-case Observational Study)

Open-Label Study of I-131-CLR1404 in Subjects With Recurrent Glioma

NCT01778088 ·Status: WITHDRAWN ·Phase: PHASE2

O6-Benzylguanine and Carmustine Implants in Treating Patients With Recurrent Malignant Glioma

NCT00004892 ·Status: COMPLETED ·Phase: PHASE1

Surgical Resection With Gliadel Wafer Followed by Dendritic Cells Vaccination for Malignant Glioma Patients

NCT00576446 ·Status: COMPLETED ·Phase: PHASE1

Nimotuzumab in Adults With Glioblastoma Multiforma

NCT00753246 ·Status: COMPLETED ·Phase: PHASE3

A Study Comparing GLIADEL to Stereotactic Radiosurgery in Metastatic Brain Disease

NCT04222062 ·Status: RECRUITING ·Phase: PHASE2

The Safety Study of Autologous TILs Therapy for Patients With Glioblastoma Multiforme.

NCT05333588 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

Clinical Study on the Safety and Efficacy of TS-2021 in the Treatment of Recurrent Malignant Glioma

NCT06585527 ·Status: RECRUITING ·Phase: PHASE1

Examination of Changes on Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy (MRS) in Patients Who Receive Gliadel Wafers During Initial Surgery for Glioblastoma Multiforme. Response or Failure to Gliadel Wafers for Subjects With Glioblastoma Multiforme.

NCT00645385 ·Status: WITHDRAWN

Study of DSP-0390 in Patients With Recurrent High-Grade Glioma

NCT05023551 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1

Study of GC101 TIL in Brain Glioma (Soochow2)

NCT04943913 ·Status: RECRUITING ·Phase: EARLY_PHASE1

Safety of BBB Opening With the SonoCloud

NCT02253212 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Clinical Trial of P134 Cells in Recurrent Glioblastoma

NCT07318818 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Randomized Phase 2 With CpG-ODN in Malignant Glioblastoma

NCT00190424 ·Status: COMPLETED ·Phase: PHASE2

Immunotherapy With Autologous Tumor Lysate-Loaded Dendritic Cells In Patients With Newly Diagnosed Glioblastoma Multiforme

NCT04801147 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Vigilant ObservatIon of GlIadeL WAfer ImplaNT Registry

NCT02684838 ·Status: COMPLETED

A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Malignant Glioma

NCT00539344 ·Status: COMPLETED ·Phase: PHASE1

Efficacy & Safety of Autologous Dendritic Cell Vaccination in Glioblastoma Multiforme After Complete Surgical Resection

NCT01006044 ·Status: COMPLETED ·Phase: PHASE2

Navigating the Clinical Research Process for Glioma

NCT05958472 ·Status: NOT_YET_RECRUITING

An Expanded Access Program of Ipilimumab for Patients With Glioblastomas and Gliomas

NCT03460782 ·Status: NO_LONGER_AVAILABLE

A Safety Study of RTA 744 in Patients With Recurrent High-Grade Gliomas

NCT00526812 ·Status: COMPLETED ·Phase: PHASE1

Vaccine Therapy in Treating Patients With Malignant Glioma

NCT00612001 ·Status: COMPLETED ·Phase: PHASE1

Phase IIa Safety and Light Dose-escalation Study in Patients With Primary or Recurrent/High-grade Glioma Using the Litx™ System to Confirm the Zone of Tumor Destruction During the Intraoperative Treatment of Glioma

NCT00409214 ·Status: COMPLETED ·Phase: PHASE2

Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Newly Diagnosed Glioblastoma

NCT03400917 ·Status: UNKNOWN ·Phase: PHASE2

A Study of Gliadel Followed by Avastin + Irinotecan for Glioblastoma Multiforme (GBM)

NCT00735436 ·Status: TERMINATED ·Phase: PHASE2

Clinical Study on the Safety and Efficacy of Novel Oncolytic Virus in the Treatment of Recurrent Malignant Glioma

NCT06562621 ·Status: COMPLETED ·Phase: PHASE1/PHASE2